天康生物(002100.SZ)控股股东拟斥1亿元至2亿元增持股份暨获不超1.4亿元增持资金贷款支持

智通财经网11-19

智通财经APP讯，天康生物(002100.SZ)公告，公司控股股东新疆生产建设兵团国有资产经营有限责任公司(简称“兵团国资公司")计划自本公告披露之日起6个月内增持公司股份，计划增持金额不少于人民币1亿元,不超过人民币2亿元。

近日，兵团国资公司已与中国光大银行股份有限公司乌鲁木齐分行(简称“光大银行”)签署《中国光大银行股票增持贷款承诺函》，光大银行承诺贷款额度不超过人民币1.4亿元，利率按银行有关规定执行，期限壹年。

更多港股重磅资讯，下载智通财经app

更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484910978?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-19 19:59","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2484910978","market":"sg","top_or_hot":-1,"title":"天康生物(002100.SZ)控股股东拟斥1亿元至2亿元增持股份暨获不超1.4亿元增持资金贷款支持","media":"智通财经网","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/002100\">天康生物</a>(002100.SZ)公告，公司控股股东新疆生产建设兵团国有资产经营有限责任公司(简称“兵团国资公司&amp;quot;)计划自本公告披露之日起6个月内增持公司股份，计划增持金额不少于人民币1亿元,不超过人民币2亿元。</p><p>近日，兵团国资公司已与<a href=\"https://laohu8.com/S/06818\">中国光大银行</a>股份有限公司乌鲁木齐分行(简称“<a href=\"https://laohu8.com/S/601818\">光大银行</a>”)签署《中国光大银行股票增持贷款承诺函》，光大银行承诺贷款额度不超过人民币1.4亿元，利率按银行有关规定执行，期限壹年。</p><p>更多港股重磅资讯，下载智通财经app</p><p>更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)</p> </body></html>","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>天康生物(002100.SZ)控股股东拟斥1亿元至2亿元增持股份暨获不超1.4亿元增持资金贷款支持</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n天康生物(002100.SZ)控股股东拟斥1亿元至2亿元增持股份暨获不超1.4亿元增持资金贷款支持\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经网</strong><span class=\"h-time small\">2024-11-19 19:59</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/002100\">天康生物</a>(002100.SZ)公告，公司控股股东新疆生产建设兵团国有资产经营有限责任公司(简称“兵团国资公司&amp;quot;)计划自本公告披露之日起6个月内增持公司股份，计划增持金额不少于人民币1亿元,不超过人民币2亿元。</p><p>近日，兵团国资公司已与<a href=\"https://laohu8.com/S/06818\">中国光大银行</a>股份有限公司乌鲁木齐分行(简称“<a href=\"https://laohu8.com/S/601818\">光大银行</a>”)签署《中国光大银行股票增持贷款承诺函》，光大银行承诺贷款额度不超过人民币1.4亿元，利率按银行有关规定执行，期限壹年。</p><p>更多港股重磅资讯，下载智通财经app</p><p>更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)</p> </body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1213074.html\">智通财经网</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1213074.html","article_id":"2484910978","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484910978","pubTimestamp":1732017541,"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，天康生物(002100.SZ)公告，公司控股股东新疆生产建设兵团国有资产经营有限责任公司(简称“兵团国资公司\")计划自本公告披露之日起6个月内增持公司股份，计划增持金额不少于人民币1亿元,不超过人民币2亿元。近日，兵团国资公司已与中国光大银行股份有限公司乌鲁木齐分行(简称“光大银行”)签署《中国光大银行股票增持贷款承诺函》，光大银行承诺贷款额度不超过人民币1.4亿元，利率按银行有","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0028":"国家队","BK0201":"可转债","BK0046":"生物疫苗","002100":"天康生物","BK0195":"猪","BK0168":"禽流感","BK0238":"农副食品"},"translate_title":"The controlling shareholder of Tiankang Biotech (002100. SZ) plans to spend 100 million to 200 million yuan to increase its shareholding and receive no more than 140 million yuan in capital loan support to increase its holdings","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002100":1},"content_text":"智通财经APP讯，天康生物(002100.SZ)公告，公司控股股东新疆生产建设兵团国有资产经营有限责任公司(简称“兵团国资公司&quot;)计划自本公告披露之日起6个月内增持公司股份，计划增持金额不少于人民币1亿元,不超过人民币2亿元。近日，兵团国资公司已与中国光大银行股份有限公司乌鲁木齐分行(简称“光大银行”)签署《中国光大银行股票增持贷款承诺函》，光大银行承诺贷款额度不超过人民币1.4亿元，利率按银行有关规定执行，期限壹年。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484910978"}